Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Relay Therapeutics (RLAY) Receivables - Net (2020 - 2023)

Historic Receivables - Net for Relay Therapeutics (RLAY) over the last 4 years, with Q3 2023 value amounting to $211000.0.

  • Relay Therapeutics' Receivables - Net fell 1244.81% to $211000.0 in Q3 2023 from the same period last year, while for Sep 2023 it was $211000.0, marking a year-over-year decrease of 1244.81%. This contributed to the annual value of $306000.0 for FY2022, which is 2406.95% down from last year.
  • Per Relay Therapeutics' latest filing, its Receivables - Net stood at $211000.0 for Q3 2023, which was down 1244.81% from $78000.0 recorded in Q2 2023.
  • In the past 5 years, Relay Therapeutics' Receivables - Net registered a high of $75.0 million during Q4 2020, and its lowest value of $78000.0 during Q2 2023.
  • In the last 4 years, Relay Therapeutics' Receivables - Net had a median value of $286000.0 in 2023 and averaged $7.1 million.
  • In the last 5 years, Relay Therapeutics' Receivables - Net tumbled by 9946.27% in 2021 and then surged by 631.97% in 2023.
  • Relay Therapeutics' Receivables - Net (Quarter) stood at $75.0 million in 2020, then crashed by 99.46% to $403000.0 in 2021, then dropped by 24.07% to $306000.0 in 2022, then crashed by 31.05% to $211000.0 in 2023.
  • Its Receivables - Net stands at $211000.0 for Q3 2023, versus $78000.0 for Q2 2023 and $286000.0 for Q1 2023.